PFRree
Latest News
Contact us
Send a Release
Login
Create Free Account
Login
Create Free Account
Abbomax
·
Newsroom
Scientists at AbboMax developed antibodies against PINK1 and Parkin to study Parkinson’s disease
A panel of PINK1 and Parkin antibodies was developed at Abbomax to investigate Parkinson’s disease (PD). These phosphospecific and paired antibodies would be the useful tools for studies of PINK/Parkin pathways and signaling in PD.
May 7, 2019
©2010-2023 PRFREE.ORG